文献速递细菌感染、耐药与抗菌药物新发突发、热带与寄生虫病

伤寒结合疫苗:应对伤寒与抗菌药物耐药的重要工具

Typhoid Conjugate Vaccine: An Urgent Tool to Combat Typhoid and Tackle Antimicrobial Resistance.
PubMed 文献 · J Infect Dis · 2021-01-01

本文为综述,指出伤寒在南亚和撒哈拉以南非洲流行,广泛耐药伤寒沙门菌蔓延,阿奇霉素成为社区治疗最后口服药,随耐药增加,泛口服耐药株可能出现。文章认为除改善水卫生外,应快速推广伤寒结合疫苗,以减轻疾病负担并遏制耐药上升。

要点

  • 伤寒在南亚和撒哈拉以南非洲流行,疾病负担加重卫生系统压力。
  • 广泛耐药伤寒沙门菌蔓延,阿奇霉素是社区治疗最后口服药。
  • 快速推广伤寒结合疫苗可减轻负担并帮助遏制耐药上升。

核心结论

  • 在伤寒流行国家快速推广伤寒结合疫苗,不仅减轻伤寒负担,也有助于遏制抗菌药物耐药上升趋势。

研究设计与样本

  • 本文为综述,讨论伤寒负担、抗菌药物耐药现状及伤寒结合疫苗的作用。

主要发现

  • 伤寒在南亚和撒哈拉以南非洲许多国家呈地方性流行。
  • 广泛耐药伤寒沙门菌正在传播,阿奇霉素是社区治疗伤寒的最后口服药物。
  • 随着阿奇霉素耐药增加,泛口服耐药伤寒沙门菌的出现迫在眉睫。
  • 伤寒高负担也是抗菌药物不必要使用的潜在原因。

临床怎么用

  • 除实施水、环境卫生和个人卫生干预外,应快速在流行国家推广伤寒结合疫苗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Typhoid is endemic in many countries in South Asia and sub-Saharan Africa. The high burden of this age-old, preventable disease exacerbates constraints on the health systems of these countries. Currently, most patients are treated effectively in the community or outpatient departments, but with rising antimicrobial resistance and the dearth of novel antimicrobials in the horizon, we risk losing our primary defense against typhoid. Extensively drug-resistant Salmonella Typhi is spreading, and azithromycin is the last oral drug to continue treating typhoid in the community. With increasing azithromycin resistance, emergence of pan-oral drug resistant Salmonella Typhi is imminent. The high burden of typhoid is also an underlying cause of the unnecessary use of antimicrobials. In addition to implementing water sanitation and hygiene interventions to prevent typhoid, it is imperative to rapidly roll out typhoid conjugate vaccines in endemic countries. This will not only reduce the burden of typhoid but will also help interrupt the trend of increasing antimicrobial resistance.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Saha SK, Tabassum N, Saha S, et al. Typhoid Conjugate Vaccine: An Urgent Tool to Combat Typhoid and Tackle Antimicrobial Resistance. J Infect Dis. 2021. PMID: 34528685. doi:10.1093/infdis/jiab443

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。